Non-Ablative Fractional Laser Treatment May Help to Reduce Skin Cancer Risk

<[cta]

A growing body of scientific evidence suggests that NAFL treatments could contribute to lowering the incidence of new skin cancers, especially in high-risk populations with extensive actinic damage or prior skin cancer history. Collectively, these studies provide compelling evidence that NAFL treatments may play a role in skin cancer prevention.

By stimulating collagen production, promoting cellular turnover, restoring immune function, and reducing premalignant lesions, these therapies may help fortify the skin’s defenses against UV-induced carcinogenesis. While promising, it is important to note that the specific Cynosure Lutronic products—such as Ultra 1927nm and Mosaic 3D 1550nm—were not directly evaluated in these studies.

Nonetheless, the biological mechanisms and clinical outcomes reported support the potential of NAFL treatments as a dual-purpose approach for both cosmetic improvement and long-term skin health preservation.

[cta]

The specific Cynosure Lutronic products, such as Ultra 1927nm and Mosaic 3D 1550nm, were not directly studied in these referenced articles. Further research is needed to confirm their efficacy in skin cancer prevention.

Intended for distribution in US and Canada.

The Ultra laser is indicated for the following: US: Intended for use in dermatological procedures requiring the coagulation of soft tissue, treatment of actinic keratosis, treatment of benign pigmented lesions, lentigos (age spots), solar lentigos (sun spots), ephelides, (freckles). Canada: Actinic keratosis (FST I-III), macular seborrheic keratoses (FST I-III), melasma (FST II-IV), skin rejuvenation (FST I-IV), and post-inflammatory hyperpigmentation (FST IV).

The Mosaic 3D laser is indicated for the following: US: Intended for use in dermatological procedures requiring the coagulation of soft tissue, as well as for skin resurfacing procedures. Canada: Intended for use in dermatological procedures requiring the coagulation of soft tissue, as well as for skin resurfacing procedures. Indications for use include wrinkles, skin rejuvenation, acne, and various scars.

Cynosure, LLC and Lutronic Aesthetic, Inc. do not diagnose or treat medical conditions, prescribe treatment protocols, provide medical advice, or otherwise practice medicine. Patient should consult with a qualified healthcare professional for diagnosis and proper treatment protocols/parameters to determine if treatment with any product is right for them. Qualified healthcare professionals are responsible for diagnosis and treatment protocols using products.

©2026 Cynosure Lutronic, Inc. All rights reserved. Lutronic is a registered trademark of Lutronic Corporation. Cynosure is a registered trademark of Cynosure, LLC.